Selectimmune Pharma B

At a glance

Most recent filing on September 27, 2019 — an open-market purchase by Johannes Wullt on Sep 26, 2019.

We hold 7 visible filings, going back to June 14, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

5 of 7 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 7. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Johannes Wullt Closely associated: Board member or deputy board member
39,797 SEKOpen-market buy
TradedSep 26, 2019FiledSep 27, 2019
Johannes Wullt Closely associated: Board member or deputy board member
24,539 SEKOpen-market buy
TradedSep 26, 2019FiledSep 27, 2019
Johannes Wullt Closely associated: Board member or deputy board member
21,084 SEKOpen-market buy
TradedSep 26, 2019FiledSep 27, 2019
Linnane Pharma AB Board member or deputy board member
50,000 sharesOther
TradedJul 10, 2019FiledJul 12, 2019
Linnane Pharma AB Board member or deputy board member
96,000 SEKOpen-market buy
TradedJun 20, 2019FiledJun 20, 2019